Drugs Based on Next-Generation Gene Editing Are Moving Toward the Clinic Faster than CRISPR 1.0

February 11, 2022

(STAT News) – In the 10 years leading up to 2012, 200 papers mentioned CRISPR. In 2020 alone, there were more than 6,000. The last decade has seen scientists use CRISPR to cure mice of progeria, fix muscular dystrophy in dogs, and eliminate symptoms for people with genetic blood disorders. Currently, there are more than two dozen human trials of the technology underway around the world. STAT has created a new tracker of milestone CRISPR studies, and found that the explosion in interest created a positive feedback loop, accelerating the movement of new and better gene editing approaches toward the clinic. (Read More)